Fanhua (FANH)
(Delayed Data from NSDQ)
$1.64 USD
-0.06 (-3.53%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $1.63 -0.01 (-0.61%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.64 USD
-0.06 (-3.53%)
Updated Oct 15, 2024 04:00 PM ET
After-Market: $1.63 -0.01 (-0.61%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Down 16.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Fanhua (FANH)
by Zacks Equity Research
Fanhua (FANH) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Should You Retain eHealth (EHTH) Stock in Your Portfolio?
by Zacks Equity Research
eHealth (EHTH) continues to benefit from growth in Medicare Advantage plan members, higher commission revenues and higher internal agent productivity.
Why Fanhua (FANH) Could Be a Top Value Stock Pick
by Zacks Equity Research
Fanhua (FANH) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Fanhua (FANH) Loses 45.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
Fanhua (FANH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
New Strong Sell Stocks for September 16th
by Zacks Equity Research
CLMT, FANH, and MORF have been added to the Zacks Rank #5 (Strong Sell) List on September 16, 2021.
Willis Tower' (WLTW) Strategy to Drive Growth, Shareholder Value
by Zacks Equity Research
Willis Towers (WLTW) reveals a strategy to boost top-line growth, return more value to shareholders, and drive long-term growth.
Top Ranked Income Stocks to Buy for August 16th
by Zacks Equity Research
NYCB, WSR, FANH, and ETH made it to the Zacks Rank #1 (Strong Buy) income stocks list on August 16, 2021.
Fanhua (FANH) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Fanhua (FANH) has been struggling lately, but the selling pressure may be coming to an end soon.
Top Ranked Income Stocks to Buy for July 30th
by Zacks Equity Research
BHP, FANH, CATY, and CHCO made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 30, 2021.
Top Ranked Income Stocks to Buy for July 28th
by Zacks Equity Research
FANH, MBWM, HFWA, and CPLP made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 28, 2021.
New Strong Buy Stocks for July 28th
by Zacks Equity Research
BNS, LNN, FANH, ABG, and CPLP have been added to the Zacks Rank #1 (Strong Buy) List on July 28, 2021.
Zacks.com featured highlights include: Dollar General, Canon, Tyler Technologies, Regeneron Pharmaceuticals and Fanhua
by Zacks Equity Research
Zacks.com featured highlights include: Dollar General, Canon, Tyler Technologies, Regeneron Pharmaceuticals and Fanhua
3 Reasons Why Fanhua (FANH) Is a Great Growth Stock
by Zacks Equity Research
Fanhua (FANH) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Zacks.com featured highlights include: Dollar General, Canon, Tyler Technologies, Regeneron Pharmaceuticals and Fanhua
by Zacks Equity Research
Zacks.com featured highlights include: Dollar General, Canon, Tyler Technologies, Regeneron Pharmaceuticals and Fanhua
Top Ranked Income Stocks to Buy for July 21st
by Zacks Equity Research
BHP, FANH, CFG, and TS made it to the Zacks Rank #1 (Strong Buy) income stocks list on July 21, 2021.
Buy These 5 Low-Beta Stocks to Beat Market Volatility
by Nilanjan Banerjee
It is imperative to build a portfolio of low-beta stocks to sail through choppy market conditions. DG, CAJ, TYL, REGN & FANH are the frontrunners.
Here's Why You Should Keep Aon (AON) Stock in Your Portfolio
by Zacks Equity Research
Riding on inorganic growth measures, Aon (AON) holds prospects of reaping benefits for investors.
Brown & Brown's Subsidiary Acquires Texas All Risk Assets
by Zacks Equity Research
Brown & Brown's (BRO) subsidiary acquires Texas All Risk, its second acquisition in the first quarter.
Arthur J. Gallagher Acquires Full Ownership of Capsicum Re
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires 100% ownership of Capsicum Reinsurance Brokers LLP.
Brown & Brown Closes Special Risk Insurance Managers Buyout
by Zacks Equity Research
Brown & Brown (BRO) completes the purchase of Special Risk Insurance Managers to expand its presence in the insurance market in Canada.
Arthur J. Gallagher Expands With Walsdorf Agency Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires Walsdorf Agency for further expansion and to support its Real Estate Practice.
5 Chinese Stocks to Keep Rallying, Trade War Wraps Up or Not
by Payal Jalan
Trade war, induced by the imposition of tariffs on imports by the United States, has hurt growth prospects of China. Despite that, some stocks performed well and have healthy prospects ahead.
Brown & Brown (BRO) Rides on Acquisitions, Cost Woes Persist
by Zacks Equity Research
Brown & Brown (BRO) is poised to grow on the back of acquisitions and prudent capital deployment slightly offset by higher expenses.
Arthur J. Gallagher Buys Canada-Based SBW Employee Benefits
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquires SBW Employee Benefits to boost its market in Atlantic Canada.
Brown & Brown's (BRO) Unit Buys Insurance Management Group
by Zacks Equity Research
Brown & Brown (BRO) acquires Insurance Management Group, its fourth buyout in the ongoing quarter.